Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.

about

Synthesis of Symmetrical Tetrameric Conjugates of the Radiolanthanide Chelator DOTPI for Application in Endoradiotherapy by Means of Click Chemistry.

P2860

Q55258405-06C7BE7D-0525-4E59-A349-D781AE494510

P2860

Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.

Item

http://www.wikidata.org/entity/Q38612027

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Dual-Nuclide Radiopharmaceutic ...... sed Dosimetry in Radiotherapy.

@en

type

Item

label

Dual-Nuclide Radiopharmaceutic ...... sed Dosimetry in Radiotherapy.

@en

prefLabel

Dual-Nuclide Radiopharmaceutic ...... sed Dosimetry in Radiotherapy.

@en

P1476

Dual-Nuclide Radiopharmaceutic ...... sed Dosimetry in Radiotherapy.

@en

P2093

Alexander Wurzer

http://www.w3.org/2001/XMLSchema#string

Alfred Morgenstern

http://www.w3.org/2001/XMLSchema#string

Christof Seidl

http://www.w3.org/2001/XMLSchema#string

Frank Bruchertseifer

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Markus Schwaiger

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide.

Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging.

In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass.

The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y.

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium.

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging

Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount

P304

547-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201702335

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Notni

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28833667

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5813229

http://www.w3.org/2001/XMLSchema#string

Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.

about

P2860

P2860

Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932